Today is: 
   
Tianyuan Bio Pharma has gained an approval for a Phase III clinical trial of its
Group A ,Group A+C+Y+W135 Meningococcal polysaccharide vaccine.
Anders Visited Tianyuan Bio-pharma
Henan Province's Symposia on the Prevention and Treatment of Influenza was held in Hangzhou
Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd.
Decision on the Employment of Mr. Richard Van Duyse as COO of Tianyuan Bio-pharma
 

User name:
Password:

If you can't see the above result, click here to insert Flash or automatic installation.
Copyright © 2003, Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd. All Rights Reserved.
Member of ChemNet.com   
CPN   Supported by Hi2000